NutriBand (NTRB) Other Non-Current Assets (2018 - 2025)
NutriBand (NTRB) posted Other Non-Current Assets of $8.4 million for Q4 2025, down 17.27% sequentially from $10.2 million in Q3 2025, and down 32.88% YoY from $12.5 million in Q4 2024.
NutriBand (NTRB) Other Non-Current Assets (2018 - 2025) Analysis & Trends
NutriBand has reported Other Non-Current Assets for 5 years, with the latest figure at $8.4 million in Q4 2025.
- Quarterly Other Non-Current Assets fell 32.88% year-over-year to $8.4 million in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $8.4 million (down 32.88% YoY) and the FY2025 annual result came in at $7.5 million, down 0.63% from the prior year.
- Other Non-Current Assets declined to $8.4 million in Q4 2025 per NTRB's latest filing, from $10.2 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $15.2 million in Q2 2024 and troughed at $250000.0 in Q1 2022.
- A 4-year average of $9.1 million and a median of $8.7 million in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets surged 3682.55% in 2023, then tumbled 59.4% in 2025.
- Over 4 years, Other Non-Current Assets stood at $250000.0 in 2022, then surged by 3309.23% to $8.5 million in 2023, then jumped by 47.17% to $12.5 million in 2024, then slumped by 32.88% to $8.4 million in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $8.4 million, $10.2 million, and $6.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 8.42 Mn |
| Jul 31, 2025 | 10.18 Mn |
| Apr 30, 2025 | 6.15 Mn |
| Jan 31, 2025 | 7.47 Mn |
| Oct 31, 2024 | 12.54 Mn |
| Jul 31, 2024 | 13.63 Mn |
| Apr 30, 2024 | 15.15 Mn |
| Jan 31, 2024 | 7.52 Mn |
| Oct 31, 2023 | 8.52 Mn |
| Jul 31, 2023 | 9.79 Mn |
| Apr 30, 2023 | 8.70 Mn |
| Jan 31, 2023 | 9.46 Mn |
| Jan 31, 2022 | 250,000.00 |
| Jul 31, 2018 | 1.85 Mn |